Your browser doesn't support javascript.
loading
Toxicologic Pathology Forum*: Opinion on Integrating Innovative Digital Pathology Tools in the Regulatory Framework.
Gauthier, Béatrice E; Gervais, Frédéric; Hamm, Gregory; O'Shea, Donal; Piton, Alain; Schumacher, Vanessa L.
Afiliación
  • Gauthier BE; 1 Sanofi, Montpellier, France.
  • Gervais F; 2 Citoxlab, Evreux Cedex, France.
  • Hamm G; 3 Pathology Sciences, Drug Safety and Metabolism IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom.
  • O'Shea D; 4 Deciphex, Dublin, Ireland.
  • Piton A; 5 ALP Quality Systems, Biot, France.
  • Schumacher VL; 6 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland.
Toxicol Pathol ; 47(4): 436-443, 2019 06.
Article en En | MEDLINE | ID: mdl-30722763
ABSTRACT
Digital pathology is defined as the ability to examine digitized microscopic slides and to generate qualitative and quantitative data. The field of digital pathology is rapidly evolving and has the potential to revolutionize toxicologic pathology. Techniques such as automated 2-D image analysis, whole slide imaging, and telepathology are already considered "mature" technologies and have been used for decades in exploratory studies; however, many organizations are reluctant to use digital pathology in regulatory toxicology studies. Innovative technologies using digitized slides including high-content imaging modalities and artificial intelligence are still under development but are increasingly used in toxicologic pathology. While software validation requirements are already described, clear guidance for application of these rules to the digital pathology field are few and the acceptance of these technologies by regulatory authorities remains necessary for successful adoption of digital pathology into the mainstream of toxicologic pathology. This topic was discussed during a roundtable at the 2018 Annual Congress of the French Society of Toxicologic Pathology. This opinion article summarizes the discussion regarding the current questions and challenges on the integration of innovative digital pathology tools within a good laboratory practice framework and is meant to stimulate further discussion among the toxicologic pathology community. *This is an opinion article submitted to the Toxicologic Pathology Forum and does not constitute an official position of the Society of Toxicologic Pathology or the journal Toxicologic Pathology. The views expressed in this article are those of the authors and do not necessarily represent the policies, positions, or opinions of their respective agencies and organizations. The Toxicologic Forum is designed to stimulate broad discussion of topics relevant to regulatory issues in Toxicologic pathology. Readers of Toxicologic Pathology are encouraged to send their thoughts on these articles or ideas for new topics to toxicologicpathologyforum@toxpath.org .
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxicología / Procesamiento de Imagen Asistido por Computador / Telepatología Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: Toxicol Pathol Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxicología / Procesamiento de Imagen Asistido por Computador / Telepatología Tipo de estudio: Guideline / Qualitative_research Límite: Humans Idioma: En Revista: Toxicol Pathol Año: 2019 Tipo del documento: Article País de afiliación: Francia